Effect of Telephonic Patient Support on Opioid Dependence

Michele Reed, PharmD
Published Online: Thursday, August 16, 2012
A recent study evaluated the impact of telephone patient support on treatment compliance and outcomes in opioid dependent patients (n = 1426) receiving buprenorphine therapy.2

Study subjects were randomized to receive buprenorphine alone or buprenorphine plus the telephonic patient support program.

Results showed that patients enrolled in the patient support program accepting at least 3 care coach intervention calls had better compliance with buprenorphine compared with the buprenorphine alone group at 12 months (64.4% vs 56.1%, respectively; P <.025).

Additionally, compliant patients reported lower Addiction Severity Index scores than noncompliant patients.

Authors concluded that the telephonic support program improved buprenorphine compliance and thus indirectly improved patient treatment outcomes.

Dr. Reed received her doctor of pharmacy degree from the University of the Sciences in Philadelphia, Pennsylvania, and currently works as a medical editor in the greater Philadelphia area.

1. Ebbeling CB, Swain JF, Feldman HA, et al. Effects of dietary composition on energy expenditure during weight-loss maintenance. JAMA. 2012;307(24):2627-2634.
2. Jakicic JM, Tate DF, Lang W, et al. Effect of a stepped-care intervention approach on weight loss in adults: a randomized clinical trial. JAMA. 2012;307(24):2617-2626.
3. Mohr DC, Ho J, Duffecy J, et al. Effect of telephone-administered vs face-to-face cognitive behavioral therapy on adherence to therapy and depression outcomes among primary care patients: a randomized trial. JAMA. 2012;307(21):2278-2285.

Latest Articles
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Latest Issues